Drylab raises 3 million to build AI scientists
On October 13 Drylab AI an autonomous agent platform learning from multimodal lab data to verify scientific hypothesis announced it had raised 3 million in its seed funding round
Drylab, an AI-driven startup founded in 2025, has secured $3 million in funding to revolutionize life sciences research. The round was led by Vertex Ventures Southeast Asia & India, with participation from PatSnap. This capital will be used to expand Drylab's team, pursue necessary certifications, and accelerate adoption in regulated industries.
John Phan, Drylab's CEO, stated, "AI is pushing the boundaries of science. Our vision is to bring that capability into the daily work of highly regulated industry like biopharma through a swarm of autonomous AI agents working alongside researchers." The company has already signed customers across leading pharmaceutical companies, cancer centers, and universities worldwide.
Genping Liu, general partner of Vertex Ventures Southeast Asia & India, added, "AI for Science is set to reinvent laboratory research. Drylab AI represents a new standard of global ambition coming out of Vietnam’s world-class tech talent pool." The company's proprietary verification model, trained on real scientific analysis runs, enables autonomous agents to correct and refine their work independently, ensuring reliability, reproducibility, and security within each organization's environment.
Drylab's technology aims to sequence biological questions into validated discoveries faster, addressing the bottleneck created by thousands of specialized bioinformatics tools, fragmented computational infrastructure, and a shortage of computational expertise in biomedical research.
Written by urgent.news from Vietnam Investment Review's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
